Frederic Waldman
18Patents
8h-index
23Co-inventors
72Inventor score
Filing activity: Jun 6, 1995 → Aug 9, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6335167B1 | Comparative genomic hybridization (CGH) | Emerging Cross-Sectional Technologies | 146 | Expired |
| US5665549A | Comparative genomic hybridization (CGH) | Chemistry; Metallurgy | 136 | Expired |
| US6159685A | Comparative genomic hybridization | Chemistry; Metallurgy | 107 | Expired |
| US5856097A | Comparative genomic hybridization (CGH) | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5721098A | Comparative genomic hybridization | Chemistry; Metallurgy | 49 | Expired |
| US5965362A | Comparative genomic hybridization (CGH) | Emerging Cross-Sectional Technologies | 41 | Expired |
| US7238484B2 | Comparative genomic hybridization | Chemistry; Metallurgy | 20 | Expired |
| US7094534B2 | Detection of chromosoal abnormalities associated with breast cancer | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7534567B2 | Detection of nucleic acid sequence differences by comparative genomic hybridization | Chemistry; Metallurgy | 3 | Expired |
| US10689710B2 | Methods for screening solid tumors for mutations | Chemistry; Metallurgy | 1 | Active |
| US11085079B2 | Universal Sanger sequencing from next-gen sequencing amplicons | Chemistry; Metallurgy | 1 | Active |
| US8021837B2 | Detection of chromosomal abnormalities associated with breast cancer | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10138519B2 | Universal sanger sequencing from next-gen sequencing amplicons | Chemistry; Metallurgy | 0 | Active |
| US11981966B2 | Methods for screening solid tumors for mutations | Chemistry; Metallurgy | 0 | Active |
| US12264357B2 | Universal Sanger sequencing from next-gen sequencing amplicons | Chemistry; Metallurgy | 0 | Active |
| US7537895B2 | Comparative genomic hybridization | Chemistry; Metallurgy | 0 | Expired |
| US11486007B2 | Methylated markers for colorectal cancer | Chemistry; Metallurgy | 0 | Active |
| US11053542B2 | Compositions and methods for screening mutations in thyroid cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.